Similar articles

• Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.

  Ilien B, Ruckstuhl M, Landry Y. Ilien B, et al. J Pharmacol. 1982 Apr-Jun;13(2):307-16. J Pharmacol. 1982. PMID: 6285085
• Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.

  Hidaka H, Hayashi H, Kohri H, Kimura Y, Hosokawa T, Igawa T, Saitoh Y. Hidaka H, et al. J Pharmacol Exp Ther. 1979 Oct;211(1):26-30. J Pharmacol Exp Ther. 1979. PMID: 226672 No abstract available.
• Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.

  Polson JB, Krzanowski JJ, Anderson WH, Fitzpatrick DF, Hwang DP, Szentivanyi A. Polson JB, et al. Biochem Pharmacol. 1979 Apr 15;28(8):1391-5. doi: 10.1016/0006-2952(79)90442-8. Biochem Pharmacol. 1979. PMID: 87201 No abstract available.
• Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.

  Nicholson CD, Shahid M. Nicholson CD, et al. Pulm Pharmacol. 1994 Feb;7(1):1-17. doi: 10.1006/pulp.1994.1001. Pulm Pharmacol. 1994. PMID: 8003849 Review. No abstract available.
• Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.

  Murray KJ, England PJ. Murray KJ, et al. Biochem Soc Trans. 1992 May;20(2):460-4. doi: 10.1042/bst0200460. Biochem Soc Trans. 1992. PMID: 1327922 Review. No abstract available.